Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication
Viruses · 2025
DOI: 10.3390/v17020284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Masmudur M Rahman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. Hauptthemen laut MEDLINE: Virus Replication, Active Transport, Cell Nucleus, Hydrazines, Triazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Health, Arizona Biomedical Research Center (ABRC).
Abstract (Originalsprache)
The nucleocytoplasmic transport of proteins using XPO1 (exportin 1) plays a vital role in cell proliferation and survival. Many viruses also exploit this pathway to promote infection and replication. Thus, inhibiting the XPO1-mediated nuclear export pathway with selective inhibitors has a diverse effect on virus replication by regulating antiviral, proviral, and anti-inflammatory pathways. The XPO1 inhibitor Selinexor is an FDA-approved anticancer drug predicted to have antiviral or proviral functions against viruses. Here, we observed that the pretreatment of cultured cell lines from human or mouse origin with the nuclear export inhibitor Selinexor significantly enhanced the protein expression and replication of mouse hepatitis virus (MHV), a mouse coronavirus. The knockdown of cellular XPO1 protein expression also significantly enhanced the replication of MHV in human cells. However, for SARS-CoV-2, Selinexor treatment had diverse effects on virus replication in different cell lines. These results indicate that XPO1-mediated nuclear export pathway inhibition might affect coronavirus replication depending on cell types and virus origin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
- School of Life Sciences Microbiology Graduate Program, Arizona State University, Tempe, AZ 85287, USA.
- School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
- Center for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
- Center for ASU-Banner Neurodegenerative Disease Research, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
ORCID-Profile: Masmudur M Rahman, Ami D Gutierrez-Jensen, Karen Kibler, Bertram Jacobs, Grant McFadden, Brenda G Hogue
Förderung
- NIDDK NIH HHS
- National Institute of Health
- Arizona Biomedical Research Center (ABRC)
- NIAID NIH HHS
- Mercatus Center Fast Grant
- Tohono O'Odham Nation Award
- Arizona State University
- Tohono O’Odham Nation Award
Zitieren
APA
Rahman, M. M., Estifanos, B., Glenn, H. L., Gutierrez-Jensen, A. D., Kibler, K., Li, Y., Jacobs, B., McFadden, G., & Hogue, B. G. (2025). Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication. Viruses. https://doi.org/10.3390/v17020284
Vancouver
Rahman MM, Estifanos B, Glenn HL, Gutierrez-Jensen AD, Kibler K, Li Y, et al. Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication. Viruses. 2025. doi:10.3390/v17020284
BibTeX
@article{Rahman2025,
author = {Rahman, Masmudur M and Estifanos, Bereket and Glenn, Honor L and Gutierrez-Jensen, Ami D and Kibler, Karen and Li, Yize and Jacobs, Bertram and McFadden, Grant and Hogue, Brenda G},
title = {Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17020284}
}
EUVIMED